Medication info
Empagliflozin 10 mg Tablet

Empagliflozin 10 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
Aprogen Pharmaceuticals Co., Ltd.
Appearance
Light yellow, round, biconvex film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102373 · Approved 2021.03.16 · Insurance code 645210960

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other antihyperglycemic agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3, Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dosage adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistently reduced glomerular filtration rate of < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dosage adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4, General Precautions).

Ingredients

Manufacturer
Aprogen Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty in blood glucose control
  • cardiovascular disease
  • occurrence of cardiovascular events
View approved original text

This medication is used to assist in dietary and exercise therapy to improve blood glucose control in adult patients with type 2 diabetes. It can be administered as monotherapy, and in some cases, it can be used in combination with metformin or other diabetes medications. For example, in cases where sufficient blood glucose control is difficult with monotherapy, it may be combined with metformin, or other drugs such as pioglitazone, sulfonylureas, or insulin. Additionally, in patients with type 2 diabetes who have cardiovascular disease, it can be cautiously administered under the guidance of a specialist. This medication effectively improves blood glucose control and is used in diabetes treatment.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other antihyperglycemic agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3, Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dosage adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistently reduced glomerular filtration rate of < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dosage adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4, General Precautions).

Precautions

This medication should not be used in certain patients. Patients with allergies to the active ingredient or any other components, patients with type 1 diabetes, and patients with diabetic ketoacidosis should not take this medication. Also, patients with very low kidney function or end-stage kidney disease, including those undergoing dialysis, should not use this medication. Furthermore, this medication contains lactose, so it is not to be administered to patients with lactose intolerance or related genetic conditions. In patients with slightly impaired kidney function, this medication should be used cautiously. If the glomerular filtration rate falls below a certain threshold, dose adjustment or discontinuation may be necessary. The efficacy of this medication is not expected in patients with end-stage kidney disease or who are on dialysis, and kidney function should be monitored regularly. In patients with heart failure, use caution in those with mild to moderate heart failure; it is not recommended for those with severe heart failure. There is a risk of hypoglycemia when this medication is used together with insulin or insulin secretagogues, so dosage adjustments may be necessary for these medications. Various adverse reactions may occur when taking this medication. The most common adverse reaction is hypoglycemia, especially increased risk when used in combination with insulin or sulfonylureas. Additionally, there may be an increase in genital infections such as vulvovaginal candidiasis, vulvitis, and balanitis. The frequency of urination may increase, and urinary tract infections may occur, so attention should be paid to symptoms. Decreased fluid volume may lead to signs of dehydration or hypotension, so caution is advised for older adults or those with low blood pressure. Increased blood creatinine levels or decreased glomerular filtration rate may occur, but this is usually temporary and resolves after discontinuation of the medication. Post-marketing studies have rare reports of severe adverse reactions, including ketoacidosis, urosepsis, pyelonephritis, skin rash, hives, angioedema, and perineal necrosis. If any of these symptoms occur, immediate consultation with healthcare professionals is necessary. Pregnant women are advised not to take this medication, and treatment should be discontinued upon confirmation of pregnancy. Nursing mothers should also discontinue breastfeeding while taking this medication. This medication has not been established for safety and efficacy in children under 18 years of age and should not be used in this population. No specific toxic symptoms have been reported in cases of overdose, but appropriate treatment should be sought if necessary. This medication should be kept out of the reach of children and should not be transferred to other containers. The risk of dehydration and hypotension may increase when this medication is used with other diuretics, so caution is warranted, and dosage adjustments may be necessary when used with insulin or insulin secretagogues to reduce the risk of hypoglycemia. Additionally, during the use of this medication, the 1,5-anhydroglucitol test, used for blood glucose control assessment, is unreliable, and alternative methods should be used. When driving or operating machinery, especially if used with insulin or sulfonylureas, there is a risk of hypoglycemia, so caution is advised. Diabetic patients should pay attention to foot care, as the risk of lower limb amputations, including toes, may increase while taking this medication. If symptoms such as pain, tenderness, or swelling occur near the perineum, there is a possibility of a severe infection, and healthcare professionals should be notified immediately.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvovaginitis
  • balanitis
  • other genital infections
  • increased urination
  • urination difficulties
  • interstitial nephritis
  • itching
  • rash
Show 229 more
  • urticaria
  • angioedema
  • decreased fluid volume
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urinary tract infection
  • urosepsis
  • pyelonephritis
  • perineal necrosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • colonic hemorrhage
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral stones
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • lumbago
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • macular retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic adenocarcinoma
  • rectal cancer
  • thyroid cancer
  • uterineleiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • upper abdominal pain
  • caries
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • enteritis
  • bloating
  • gastric polyps
  • gingival swelling
  • passage of blood in stool
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • paronychia
  • tinea corporis
  • dental abscess
  • nasopharyngitis
  • positional vertigo
  • sensory loss
  • paresthesia
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory impairment
  • neuralgia
  • Parkinson's disease
  • peripheral neuropathy
  • sensory dysfunction
  • drowsiness
  • CNS-origin vertigo
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • strange sensation
  • edema
  • pain
  • pain at puncture site
  • chest pain
  • weight gain
  • electrocardiogram abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • urinary abnormalities
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • somnolence
  • hyperlipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • conjunctival injection
  • eyelid swelling
  • visual impairment
  • floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual phlegm
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • atherosclerosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • hepatitis
  • otalgia
  • positional vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • upper respiratory infection
  • shingles
  • dizziness
  • chest discomfort
  • asthenia
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is recommended to keep it in a cool place at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Light yellow, round, biconvex film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.